Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype

Daisuke Ennishi, MD PhD, Anja Mottok, MD, Kerry J. Savage, MDMSc, Susana Ben-Neriah, Hennady Shulha, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, Merrill Boyle, BSc, Christoffer E Hother, MD PhD, Robert Kridel, MD MPH, Ryan Morin, PhD, Marco A Marra, PhD, Laurie H. Sehn, Christian Steidl, MD, Joseph M. Connors, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne

Blood (2015) 126 (23): 109.

https://doi.org/10.1182/blood.V126.23.109.109

Published: 2015

Journal Articles

Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma

Daisuke Ennishi, MD PhD, Anja Mottok, MD, Hennady Shulha, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, Merrill Boyle, BSc, Susana Ben-Neriah, Christoffer E Hother, MD PhD, Robert Kridel, MD MPH, Ryan Morin, PhD, Marco A Marra, PhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, Joseph M. Connors, MD, Christian Steidl, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne

Blood (2015) 126 (23): 111.

https://doi.org/10.1182/blood.V126.23.111.111

Published: 2015

Journal Articles

NOTCH1 Induces Differential Epigenomic Patterning and Genomic Organization in Fetal Liver- and Adult Bone Marrow-Derived Hematopoietic Progentiors

Vincenzo Giambra, PhD, Sonya H Lam, Miriam Belmonte, Sam Gusscott, Sohrab Salehi, Fong Chun Chan, Robert Kridel, MD MPH, Alireza Lorzadeh, Catherine Hoofd, PhD, Christian Steidl, MD, Connie J. Eaves, PhD, Martin Hirst, PhD, Andrew P. Weng, MD PhD

Blood (2015) 126 (23): 3637.

https://doi.org/10.1182/blood.V126.23.3637.3637

Published: 2015

Journal Articles

A Clinicogenetic Risk Model (m7-FLIPI) Prospectively Identifies One-Half of Patients with Early Disease Progression of Follicular Lymphoma after First-Line Immunochemotherapy

Blood (2015) 126 (23): 333.

https://doi.org/10.1182/blood.V126.23.333.333

Published: 2015

Journal Articles

Mass Cytometry Based Classification of Inter- and Intra-Tumoral Heterogeneity in Diffuse Large B-Cell Lymphoma

Manabu Kusakabe, MDPhD, Xuehai Wang, PhD, Guillermo Simkin, PhD, Justin Meskas, MSc, Chaoran Zhang, Daisuke Ennishi, MD PhD, Robert Kridel, MD MPH, Merrill Boyle, BSc, Elizabeth Chavez, BSc, Stacy Hung, PhD, David W Scott, MBChB, PhD, Christian Steidl, MD, Randy D. Gascoyne, Ryan R. Brinkman, PhD, Andrew P Weng, MD PhD

Blood (2015) 126 (23): 3908.

https://doi.org/10.1182/blood.V126.23.3908.3908

Published: 2015

Journal Articles

Disruptive ARID1A Mutations in Follicular Lymphoma Impair DNA Repair Efficiency and Are Associated with Favorable Outcome in Patients Receiving First-Line Immunochemotherapy

Deepak Bararia, PhD, Michael Heide, Robert S. Welner, PhD, Tatiana Romashova, Alessandro Pastore, MD, Radhika Mathur, Randy D. Gascoyne, Robert Kridel, MD MPH, Boris G. Willson, PhD, Charles W.M. Roberts, MD PhD, Wolfgang Hiddemann, MD PhD, David M Weinstock, MD, Oliver Weigert, MD

Blood (2015) 126 (23): 571.

https://doi.org/10.1182/blood.V126.23.571.571

Published: 2015

Journal Articles

Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry

David W. Scott, MBChB, PhD, Anja Mottok, MD, Daisuke Ennishi, MD PhD, George W. Wright, PhD, Pedro Farinha, MD, Susana Ben-Neriah, MSc, Robert Kridel, MD MPH, Garrett S Barry, B.Sc, Christoffer E Hother, MDPhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Louis M. Staudt, Joseph M. Connors, MD, Lisa M. Rimsza, MD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 1624.

https://doi.org/10.1182/blood.V124.21.1624.1624

Published: 2014

Journal Articles

Whole Transcriptome Sequencing Reveals Recurrent NOTCH1 Mutations in Mantle Cell Lymphoma

Robert Kridel, MD, MPH, Barbara Meissner, PhD, Sanja Rogic, PhD, Merrill Boyle, B.Sc., Adele Telenius, M.Sc., Jay Gunawardana, M.Sc., Chris Cochrane, Arla J Yost, David W Scott, MBChB PhD, King Tan, MBBS, Bruce Woolcock, M.Sc., Susana Ben-Neriah, Stephen Opat, MD, Laurie H. Sehn, MD, MPH, Joseph M. Connors, MD, Andrew P Weng, MD, PhD, Christian Steidl, MD, Randy D. Gascoyne, MD

Blood (2011) 118 (21): 436.

https://doi.org/10.1182/blood.V118.21.436.436

Published: 2011

NARROW

Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype

Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma

NOTCH1 Induces Differential Epigenomic Patterning and Genomic Organization in Fetal Liver- and Adult Bone Marrow-Derived Hematopoietic Progentiors

A Clinicogenetic Risk Model (m7-FLIPI) Prospectively Identifies One-Half of Patients with Early Disease Progression of Follicular Lymphoma after First-Line Immunochemotherapy

Mass Cytometry Based Classification of Inter- and Intra-Tumoral Heterogeneity in Diffuse Large B-Cell Lymphoma

Disruptive ARID1A Mutations in Follicular Lymphoma Impair DNA Repair Efficiency and Are Associated with Favorable Outcome in Patients Receiving First-Line Immunochemotherapy

Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry

Whole Transcriptome Sequencing Reveals Recurrent NOTCH1 Mutations in Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only